Related Experiment Video
Updated: Aug 21, 2026

Cities As Interfaces of Zoonotic Hazard Emergence: Development of the New York City Tick and Wildlife Urban Surveillance System
Published on: March 10, 2026
Non-fatal firearm violence across 17 US cities using police dashboard data, 2020-2025
Maureen R Benjamins1,2, Cameron De La Huerta2, Nazia S Saiyed1
1Sinai Urban Health Institute, 1500 S. Fairfield Ave, Chicago, IL 60608, USA.
Objective:
Non-fatal firearm violence is a substantial, but often overlooked, public health burden in the United States (US); however, local data infrastructure remains limited. We identified and summarized city-level public dashboards reporting non-fatal firearm violence.
Methods:
In this descriptive epidemiologic study, we searched for US cities with publicly available dashboards reporting local police-reported non-fatal firearm violence. We then compared violence counts, population-based rates, and trends from 2020 to 2025.
Results:
Only 17 cities, varying by size and geography, met the inclusion criteria. Rates of non-fatal firearm violence varied nearly eight-fold across cities in 2025, ranging from 13.3 per 100,000 (Seattle, Washington) to 106.0 (Portsmouth, Virginia). Annual non-fatal shootings ranged from 83 (Pittsburgh, Pennsylvania) to 1515 (Chicago, Illinois). Most cities saw a spike in non-fatal firearm violence during the peak of the COVID-19 pandemic (2021), followed by a decline through 2025.
Conclusions:
Only 17 US cities had publicly available dashboards reporting police-reported non-fatal firearm violence. Given the substantial variation in rates across cities, publicly available local dashboards can strengthen firearm injury surveillance, enable city-level comparisons, and inform violence prevention policies and programs.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Investigation of Disease Outbreaks
Levels of Use of a GIS
Statgraphics
Principles of Disease Surveillance
Hazard Ratio
For example, in a clinical trial evaluating a...